Northern Trust Corp Night Hawk Biosciences, Inc. Transaction History

Northern Trust Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.83 - $1.24 $402 - $601	-485 Reduced 1.03%	46,817 $40,000
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $25 - $41	-14 Reduced 0.03%	47,302 $82,000
Q4 2021 Feb 08, 2022	BUY	$3.04 - $6.01 $167 - $330	55 Added 0.12%	47,316 $144,000
Q3 2021 Nov 15, 2021	BUY	$5.9 - $7.44 $2,537 - $3,199	430 Added 0.92%	47,261 $282,000
Q2 2021 Aug 13, 2021	BUY	$5.78 - $9.6 $25,559 - $42,451	4,422 Added 10.43%	46,831 $315,000
Q1 2021 May 12, 2021	BUY	$5.67 - $12.54 $14,951 - $33,067	2,637 Added 6.63%	42,409 $308,000
Q4 2020 Feb 11, 2021	BUY	$5.28 - $9.59 $209,996 - $381,413	39,772 New	39,772 $213,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.